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ABSTRACT
Radiation therapy (RT) delivers tumour kill, directly and often via bystander 
mechanisms. Bladder toxicity is a dose limiting constraint in pelvic RT, manifested 
as radiation cystitis and urinary symptoms. We aimed to investigate the impact of 
radiation-induced bystander signaling on normal/cancer urothelial cells. Human 
urothelial cancer cells T24, HT1376 and normal urothelial cells HUC, SV-HUC were 
used. Cells were irradiated and studied directly, or conditioned medium from irradiated 
cells (CM) was transferred to naïve, cells. T24 or SV-HUC cells in the shielded half of 
irradiated flasks had increased numbers of DNA damage foci vs non-irradiated cells. A 
physical barrier blocked this response, indicating release of transmitters from irradiated 
cells. Clonogenic survival of shielded T24 or SV-HUC was also reduced; a physical barrier 
prevented this phenomenon. CM-transfer increased pro-apoptotic caspase-3 activity, 
increased cleaved caspase-3 and cleaved PARP expression and reduced survival protein 
XIAP expression. This effect was mimicked by ATP. ATP or CM evoked suramin-sensitive 
Ca2+-signals. Irradiation increased [ATP] in CM from T24. The CM-inhibitory effect on 
T24 clonogenic survival was blocked by apyrase, or mimicked by ATP. We conclude 
that radiation-induced bystander signaling enhances urothelial cancer cell killing via 
activation of purinergic pro-apoptotic pathways. This benefit is accompanied by normal 
urothelial damage indicating RT bladder toxicity is also bystander-mediated.
INTRODUCTION
The goal of radiation therapy (RT) is to maximize 
the probability of tumour control whilst minimizing 
damage to surrounding normal tissue. RT for bladder, 
prostate and cervical pelvic malignancies is associated 
with radiation-induced bladder toxicity (RIBT) which 
typically manifests as lower urinary tract symptoms [1–4] 
due to unavoidable dose delivered to neighbouring normal 
tissues. Generation of reactive oxygen species and reactive 
nitrogen species interact with DNA, resulting in damaged 
lesions including lethal double stranded breaks (DSB) 
which underpins RT cellular damage. Many cells repair 
DNA damage through homologous recombination or non-
homologous end joining to maintain genome integrity 
while others, including tumour cells lack effective repair 
mechanisms and undergo cell death.
Radiation-induced bystander effects describe 
biological phenomena where non-irradiated cells respond 
to irradiated neighbouring cells [5]. Therefore, the cellular 
radiation response incorporates both direct effects and 
indirect bystander effects leading to genetic instability, 
diminished survival, apoptosis and necrosis. Bystander 
mechanisms include intercellular communication via gap 
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junctions and release of transmitters into the extracellular 
space (or culture media) which then act in an autocrine 
and paracrine manner. Radiation bystander effects have 
been described in normal bladder explants correlated 
with aberrant urothelial outgrowth [6–9] which may be a 
protective response to urothelial loss that occurs during RT 
[10], associated with irritative radiation cystitis [11, 12]. In 
the context of urothelial cancer, studies using the bladder 
transitional cancer cell line, EJ138, have demonstrated 
decreased clonogenic cell survival after transfer of 
medium from irradiated cells, an effect which saturated at 
2Gy, consistent with a bystander response [13–15].
The present study tested the hypothesis that 
‘radiation bystander signaling occurs in urothelial 
cancer cells’ and compared the radiobiological response 
mechanisms with normal urothelial cells. Investigations of 
DNA damage, clonogenic cell survival and the underlying 
pathways showed that radiation-induced bystander 
signaling via purinergic pathways attenuates urothelial 
cancer cell survival with similar effects on normal 
urothelial cells which would explain lesions leading to 
radiation cystitis and RIBT.
RESULTS
Tumour and normal urothelial cells exhibit 
radiation-bystander effects
Nuclear foci comprising 53BP1 proteins [16] 
formed around DNA DSB are used to quantify DNA 
damage. Automatic foci-scoring of confocal z-stacks was 
used to minimise any investigator-related unconscious 
bias [17]. Foci were measured in cells within non-
irradiated, uniformly irradiated and shielded/exposed 
flasks (Figure 1A, Supplementary Figure 1). Cells were 
fixed and processed for 53BP1-immunofluorescence one 
hour following irradiation exposure. X-ray irradiation 
(1Gy) increased the mean number of 53BP1 foci in 
uniformly-irradiated (17.9±1.3) vs non-irradiated T24 
(3.6±0.4, p<0.0001, Figure 1B). Foci in exposed regions 
were similar to cells in uniformly-irradiated chambers 
(p>0.05). Interestingly, the number of foci in shielded 
regions (up to 5mm from the analysis region at the flask 
centre) was larger than in non-irradiated cells (7.1±1.2; 
p=0.019) consistent with bystander signaling as the dose 
in this region was only 0.03 Gy. Although not statistically 
significant, the data suggest that foci in the adjacent 
shielded region (5-10mm) also increased slightly (5.1±0.6) 
vs control (p=0.07).
HT1376 urothelial carcinoma cells, had the expected 
increased foci in uniformly-irradiated vs non-irradiated flasks 
(Figure 1C), however, similar numbers of foci per nucleus 
in shielded regions vs non-irradiated cells were observed 
(p>0.05) indicating absence of a bystander response.
Normal HUC (Figure 1D) also had increased 
numbers of foci per nucleus in uniformly-irradiated 
(18±2.0) vs non-irradiated (6.1±0.6, p=0.0002) flasks. 
Similar to T24, the number of foci in HUC from 
uniformly-irradiated chambers was similar to exposed 
regions (p>0.05). The number of foci per nucleus in 
shielded sections were larger than in non-irradiated 
chambers (0-5mm 9.6±0.8, p=0.005; 5-10mm 9.1±1.1, 
p=0.04) consistent with bystander signalling.
Physical barrier abolishes bystander DNA DSB 
foci
To investigate whether intercellular communication 
through transmitter release from irradiated cells 
contributed to bystander DSB in shielded regions, 
communication between shielded and exposed regions 
was physically inhibited. The bystander effect observed 
in Figure 1 was abolished in the shielded region for 
both T24 (Figure 2A) and HUC (Figure 2B) cells when 
communication was physically inhibited.
Relative radiosensitivities of urothelial cells and 
impact of radiation on cell survival
Relative cellular radiosensitivities were investigated 
in clonogenic survival assays over 0.5Gy-8Gy dose-range. 
Summary data of the surviving fractions (Figure 3A) 
demonstrates HT1376 cells to be more radioresistant and 
normal SV-HUC and T24 to be more radiosensitive.
Cell survival curves were fitted with Linear Quadratic 
(LQ) modelling (Figure 3B) which confirmed SV-HUC 
as the most radiosensitive (α=0.43±0.07) particularly 
>2Gy. T24 were also radiosensitive (α=0.30±0.03) >2Gy 
compared with the relatively radioresistant HT1376 
(α=0.12±0.002), consistent with [18]. HUC radiosensitivity 
could not be assessed due to inability of these cells to form 
colonies.
Cells were irradiated in T25 flasks either uniformly 
or in shielded/exposed flasks (Supplementary Figure 2). 
Summary survival curves (Figure 3C-3E) were determined 
for each condition where the surviving fraction is plotted 
against dose, which for shielded regions is the calculated 
scattered dose, shown in the insets on an expanded scale 
(Figure 3B). As bystander responses typically saturate 
and do not affect the whole cell population, the non-
responding cell population is defined as P (bystander 
limit), and the rate of bystander response is characterised 
by γ. The shielded region survival is therefore SF=P+(1-
P)*exp(-γ*D), where D is the dose delivered to the exposed 
part. The initial slope of this curve is (1-P)*γ, comparable 
to α in the LQ [19].
T24 in exposed sections had increased survival 
(8Gy) vs uniformly-irradiated cells, indicative of a 
bystander-mediated advantage. Similar analysis of cells in 
shielded sections showed decreased survival (P=0.7±0.02, 
γ=58.3±17, (1-P)*γ=17.5), an effect which saturated at a 
scattered dose of 0.05Gy at 70% survival.
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The exposed section survival of SV-HUC cells 
(α=0.43±0.07) was reduced compared with uniformly-
irradiated (α=0.47±0.03) at 4Gy. Cell survival in 
shielded regions was decreased compared with LQ 
prediction and reached 60-80% at a scattered dose of 
0.24Gy (P=0.7±0.02, γ=166.6±134, (1-P)*γ=44.9). The 
radioresistant HT1376 in exposed sections were similar to 
uniformly-irradiated. Likewise, the survival curve for the 
shielded region matched uniformly-irradiated and exposed 
sections showing a lack of bystander response.
Bystander cell survival effect was prevented by a 
physical barrier
To assess the involvement of intercellular 
communication, cells were seeded in 6-well plates, where 
communication between shielded and exposed cells was 
physically inhibited. Cell survival curves for T24 or 
SV-HUC in exposed sections (Supplementary Figure 3) 
were similar to uniformly irradiated flasks; moreover, 
cell survival curves for shielded sections was close to 
that predicted by the LQ model. These results indicate a 
direct role for cell communication in bystander survival 
responses of T24 and SV-HUC.
Irradiation evokes ATP release from T24 cells
CM transfer from irradiated cells to non-irradiated 
cells is a common protocol to investigate bystander effects. 
Controls were performed where CM was transferred 
from non-irradiated cells to naïve cells. CM significantly 
decreased T24 clonogenic survival (p<0.05, Figure 4A) 
therefore Western blots of pro-apoptotic pathways were 
performed on T24 that were directly-irradiated or received 
Figure 1: Bystander signaling evokes DNA damage foci formation in urothelial cancer and normal urothelial cells. (A) 
Schematic representation of experimental conditions including non-irradiated, uniformly-irradiated and shielding protocols where 50% 
of the slide was exposed and 50% shielded with MCP alloy. Cells were fixed and processed for 53BP1-immunofluorescence, one hour 
following irradiation. Micrographs of urothelial cancer T24 cells labelled with anti-53BP1 (green) to label nuclear DNA double stand break 
foci and DAPI to counterstain nuclei are shown for each experimental condition. (B) Summary graph of mean foci/cell in T24 cells (N=3), 
measured from confocal z-stacks in Volocity software. There were significantly more foci in shielded cells 0.5mm from the shield than in 
non-irradiated controls, indicative of a bystander effect (p=0.019). (C) Summary data for HT1376 cancer cells (N=3) where there was no 
difference in the mean foci/cell between non-irradiated controls and shielded cells. (D) Summary data for normal urothelial HUC (N=3). 
Mean foci/cell was significantly greater in shielded cells in the 0-5mm (p=0.005) and 5-10mm (p=0.04) analysis regions from the shield. * 
denotes p<0.05, ** denotes p<0.01
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CM. In both conditions, cells expressed increased pro-
apoptotic proteins; cleaved caspase-3, cleaved PARP and 
reduced XIAP (inhibitor of apoptosis proteins). ATP release 
after irradiation has been reported in other cells [20]; in T24, 
ATP was enhanced in CM at 20 min post-irradiation and was 
significantly enhanced in CM 1h post-irradiation, analysed 
with 1-way ANOVA (P=0.0065) (Figure 4C) and with post-
hoc Dunnett’s test from 15.3±0.3nM (non-irradiated) to 
21.9±1.5nM (0.5Gy, P<0.01), 22.1±1.5nM (8Gy P<0.01) 
and 22.5±1.1nM (8Gy P<0.01). When the two timepoints 
were combined for 2-way ANOVA, radiation exposure had 
a significant effect (P=0.03) whereas time had no overall 
effect (P>0.05). These experiments were carried out in the 
presence of the ectoATPase inhibitor, ARL67156 to prevent 
ATP hydrolysis.
ATP modulates bystander signalling in T24 cells
To independently test whether ATP within CM 
decreased cell survival, exogenous ATP was applied to T24 
(10nM-1mM) and dose-dependently decreased survival, 
IC50 0.29mM (Figure 4D). Interestingly, T24 require basal 
ATP for physiological survival and either excess (Figures 
4D and 5C) or decreased ATP levels (Figure 5A) reduced 
survival. The ATP diphosphohydrolase, apyrase (breaks 
down ATP, 10U/ml) decreased the surviving fraction to 
0.83±0.05 (p<0.05, Figure 5A), confirmed by the presence 
of cleaved caspase-3 and cleaved PARP, consistent with 
activation of apoptosis (Figure 5B). Enhancement of basal 
ATP with the ectoATPase inhibitor ARL67156 (100μM, 
prevents ATP breakdown) reduced the surviving fraction 
to 0.58±0.08 (p<0.05, N=3, Figure 5C) demonstrating the 
importance of extracellular ATP homeostasis.
In further experiments, flasks were pre-treated 
with apyrase (30min) and irradiated in exposed/shielded 
sections (2Gy). Non-irradiated controls, with/without 
apyrase were included. As apyrase decreases T24 
survival (Figure 5A), survival responses in shielded/
exposed cells were calculated relative to apyrase-
treated, non-irradiated controls. Apyrase rescued the 
surviving fraction in shielded sections (0.75±0.03 to 
0.94±0.06, N=3, p<0.01), consistent with ATP-modulated 
bystander signalling. Confirmation that ATP activated 
pro-apoptotic signaling pathways, mimicking the CM 
effect is presented in Figure 5E, where ATP dose-
dependently increased cleaved caspase-3, cleaved PARP 
and decreased XIAP expression.
Bystander signaling or ATP activates pro-
apoptotic pathways in normal urothelial cells
We then investigated whether similar pathways 
occur in normal urothelial cells. In SV-HUC (Figure 5F), 
direct irradiation enhanced cleaved caspase-3 and cleaved 
PARP expression; this was more apparent in CM-treated, 
non-irradiated cells. Interestingly, while direct irradiation 
Figure 2: Bystander DNA damage foci are prevented by a physical barrier. Schematic representation of experiments similar 
to those presented in Figure 1, with a physical barrier between shielded and exposed sections. Cells were fixed and processed for 53BP1-
immunofluorescence one hour following irradiation. (A) Inclusion of a physical barrier prevented formation of bystander DNA damage 
foci in shielded T24 cells (N=3). (B) Similarly, the physical barrier prevented formation of bystander DNA damage foci in shielded HUC 
cells (N=3).
Oncotarget97335www.impactjournals.com/oncotarget
did not impact pro-survival XIAP expression, CM blocked 
XIAP expression, showing that bystander signaling further 
promoted apoptosis. These findings were mimicked by ATP 
(Figure 5G) confirming ATP-mediated toxicity in SV-HUC.
Purinergic-mediated bystander signaling in T24 
cells is Ca2+-dependent
Exogenous application of ATP (10-5M) to fluo-
4AM loaded T24 cells evoked increases in fluorescence, 
indicating increased intracellular [Ca2+]. This concentration 
of ATP was found (above) to significantly decrease T24 
clonogenic cell survival. ATP-evoked responses were 
repeatable after a 10 min washout. After control responses 
were obtained (Figure 6A), cells were washed and exposed 
to the pan-purinergic receptor blocker, suramin for 30 min 
(10-4M). Subsequent application of ATP in the presence of 
suramin evoked significantly smaller responses (ΔF/F0 from 
3.5±0.4, to 1.7±0.2, N=3, n=51 cells; p<0.001, Figure 6B).
To examine whether conditioned medium (CM) 
from irradiated cells could evoke Ca2+-transients, CM 
from non-irradiated (0 Gy) or irradiated (8Gy, 1h after 
irradiation) cells was applied. Intensity-time plots for 
Ca2+-transients evoked by CM from control (0Gy) and 
8Gy experiments are shown in Figure 6C. Both 0Gy CM 
and 8Gy CM evoked Ca2+ transients in recipient cells, 
consistent with the finding that ATP is released from 
non-irradiated cells and at a larger concentration from 
irradiated cells (see above). To determine whether the CM-
evoked responses were mediated by purinergic signaling, 
CM from cells from control 0 Gy or 8 Gy irradiated cells 
was applied (applications were separated by a 10 minute 
Figure 3: The bystander effect decreases cell survival of T24 and SV-HUC. (A) Surviving fraction of T24, HT1376 and SV-
HUC cells plotted against the radiation dose range 0.5Gy-8Gy (all N=3). HT1376 cells were the most radioresistant and normal SV-HUC 
were most radiosensitive. (B) Summary data from linear quadratic (LQ) modelling of survival curves for the 3 cell lines in uniformly-
irradiated, shielded and exposed conditions shown in panels (C-E) α represents a single hit killing mechanism e.g. non-reparable DNA 
double stand breaks, greatest in SV-HUC whereas β represents multiple hit processes. The α/β ratio represents the dose at which both 
processes play an equal role e.g. the higher the ratio, the less repair will be occurring. The γ value shows the response rate where a higher 
value describes rapid response. Here, SV-HUC have the highest γ therefore the highest fraction of cells responding at the highest rate. 
(C) Survival curve for T24 under the 3 conditions (N=3). At 8Gy, cells in the exposed section had a survival advantage compared with 
uniformly-irradiated cells indicative of a protective bystander effect. Inset shows decreased survival of shielded cells plotted against the 
calculated scattered dose during each exposure and saturates around 70% survival at a scattered dose of 0.05Gy. (D) Similar curves for 
HT1376 (N=3) showing absence of a bystander effect on survival with little effect on shielded cells. (E) SV-HUC cells had a marked 
bystander response with decreased survival in shielded cells (N=3) that saturated at 60-80% survival at a scattered dose of 0.24Gy.
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wash) and subsequently, cells were incubated with suramin 
(10-4M) for 30 minutes. Suramin reduced the percentage 
of cells responding to both 0Gy from 90.4±6.2% to 21.5 ± 
18.9% and 8Gy from 82.3±12.6% to 5.5±1% (8Gy) (N=3, 
n=72, Figure 6D).
DISCUSSION
These novel findings demonstrate the impact of 
radiation-induced bystander signaling in cell death of 
normal and cancer urothelial cells. Radiation-induced 
bystander signaling is potentially both advantageous through 
maximizing tumour cell death and undesirable through 
damage to normal urothelial cells, contributing to RIBT.
The typical tumour response to radiation is largely 
determined by radiosensitivity of cancer cells [21]. Here, 
normal SV-HUC were most radiosensitive, and HT1376 
urothelial cancer cells were most radioresistant, consistent 
with [18]. Normal urothelial cell radiosensitivity is 
important clinically as the urothelium is important in post-
irradiation bladder pathogenesis [22]. Divergence of the 
SV-HUC survival curve from urothelial cancer cells >2Gy 
represents the typical radiation response of increased 
radiosensitivity in normal cells. This rationale underpins 
standard clinical 2Gy dose fractions as an optimal balance 
between cancer cell kill and normal cell protection [4].
LQ modelling of cell survival demonstrates total 
lethal lesions comprising those produced by: (1) a single 
hit (linearly related to dose) and (2) two hits (quadratically 
related to dose) [23]. The similar α/β ratio found here 
between T24, HT1376 and SV-HUC cells shows that 
differences in radiosensitivity were not due to different 
types of damage, produced by multiple hits, but may 
potentially represent deregulated cell cycle control in 
the cancer cell lines (particularly HT1376) however, this 
was not directly investigated in the present study. Here, 
the bystander effect correlated with radiosensitivity 
and was absent in the most resistant cell line. Cells are 
Figure 4: Radiation-induced bystander effects diminish cell survival of T24 cells. (A) Application of conditioned medium 
(CM) from irradiated (2Gy, 8Gy) T24 to non-irradiated cells significantly decreased clonogenic cell survival (N=3, p<0.05). Control 
experiments used CM from non-irradiated cells (Gy). (B) T24 cells that were directly irradiated (2Gy) or received CM from directly-
irradiated cells (2Gy) were processed for Western blotting. CM evoked expression of cleaved caspase-3, cleaved PARP and reduced XIAP 
expression, consistent with activation of pro-apoptotic signaling (represents N=3). (C) ATP concentration was enhanced in CM obtained 
from cells 20 min post-irradiation at 0.5Gy, 2Gy and 8Gy and was significantly increased in CM obtained from cells irradiated at 0.5Gy, 
2Gy and 8Gy (N=3, p<0.01) one hour post-irradiation. ARL67156 (50μM), an ectoATPase inhibitor, was included in these experiments to 
prevent ATP hydrolysis. (D) T24 clonogenic cell survival was concentration-dependently decreased by exogenous ATP treatment with an 
IC50 of 0.29mM (N=3).
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typically most radiosensitive in M and G2 phases while 
most are radioresistant in S phase. For cells with a long 
cycle e.g. HT1376 (doubling time 36h vs 19h T24), there 
is also increased resistance in early G1. Correlation of 
radiosensitivity and length of the cell cycle has been 
shown in cell lines [24] and lymphocytes [25]. In other 
studies, irradiated regions of human urothelial explants 
using microbeams correlated with differentiation and 
proliferation status resulting in outgrowth of neighbouring 
non-irradiated regions [6, 7].
The shielding vs exposed experimental design 
models Intensity-Modulated RT (IMRT) where cells 
are irradiated close to neighbouring non-irradiated cells 
and steep dose-gradients exist. For cells with bystander 
effects (T24 and SV-HUC), survival in the shielded region 
was lower than that predicted from the scattered dose. 
Bystander effects were absent in radioresistant HT1376 
cells showing correlation between radiosensitivity and 
bystander signaling, consistent with [19].
T24 cancer cells in exposed regions had increased 
survival at high doses, vs uniformly-irradiated, suggesting 
a counteracting effect to the decreased survival of shielded 
cells; a similar phenomenon has been reported for other 
cell lines [19, 26, 27]. SV-HUC showed opposite effects, 
where exposed cells had decreased survival vs uniformly-
irradiated regions. In SV-HUC, there might be greater 
damage in IMRT type regimens even at therapeutically 
relevant 2Gy fractions.
T24, HT1376 and HUC had significantly increased 
53BP1 foci, one hour after irradiation. Interestingly, in 
shielding experiments, increased 53BP1 foci occurred 
in shielded T24 (0-5mm) and SV-HUC (0-10mm) from 
the edge of the shield. A similar phenomenon has been 
reported for prostate cancer DU145 cells [19] similar to 
the findings here, where increased DNA damage foci 
within the region closest to the border of the shielding 
is consistent with diffusion of transmitters from cells 
in exposed sections. The prevention of bystander DNA 
Figure 5: Radiation-induced bystander effects in urothelial cancer and normal urothelial cells is mediated by 
purinergic-signalling. (A) The ATP diphosphohydrolase, apyrase (10U/ml) significantly decreased T24 cell survival (N=3, p<0.05). 
(B) Apyrase (10U/ml) treatment increased expression of cleaved caspase-3 (C-Casp-3) and cleaved PARP (C-PARP). Total caspase-3 and 
total PARP are abbreviated to T-CASP-3 and T-PARP-3 respectively (represents N=3). (C) ARL67156 (100μM), an ectoATPase inhibitor 
decreased T24 cell survival (N=3, p<0.05). (D) In shielding protocols, the decreased survival of shielded cells was rescued by apyrase 
treatment N=3, p<0.01). Survival was corrected for apyrase effects on non-irradiated cells. (E) ATP activated pro-apoptotic signaling in a 
concentration-dependent manner with increased expression of cleaved caspase-3, cleaved PARP and decreased XIAP expression (N=3). (F) 
Similar experiments were performed on normal SV-HUC cells; directly irradiated cells had upregulation of cleaved caspase-3 and cleaved 
PARP. CM also increased expression of these proteins and also inhibited expression of XIAP. (G) The CM bystander effect on normal SV-
HUC was mimicked by ATP treatment across a concentration range.
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foci in shielded cells by a physical barrier supports 
this hypothesis. Interestingly, consistent with absence 
of a bystander cell survival effect in the radioresistant 
HT1376 cells, increased foci per nucleus did not occur 
in the shielded region.
The finding that radiation enhanced ATP release 
from T24 cells indicated that ATP within CM might be a 
candidate for mediating the bystander effect. This was 
confirmed by a dose-dependent reduction of cell survival by 
ATP and its activation of pro-apoptotic signaling pathways. 
Activation of executioner caspase-3 by proteolytic cleavage 
of its pro-enzyme is an apoptosis hallmark. Active caspase-3 
cleaves and impairs the DNA-repair enzyme poly-ADP 
ribose polymerase (PARP), which compounds DNA 
damage directing cells towards apoptosis [28]. T24 rely on 
basal ATP for survival as promotion or prevention of ATP 
breakdown by apyrase or ARL67156 respectively reduced 
survival, indicative of ATP homeostasis. The enhanced 
release of ATP by radiation therefore unsurprisingly leads 
to apoptosis and associated signaling pathways. Rescue 
of survival reduction in shielded cells from bystander 
signaling by apyrase further supports the role of ATP 
release from irradiated cells which diminished cell survival 
in neighbouring cells. Reduction of xenograft urothelial 
[29] or prostate [30] tumour growth by daily intraperitoneal 
injections of ATP (mM) has been reported, moreover, 
inhibition of purinergic receptors also decreases tumour 
growth [31].
ATP acts as a signaling molecule via purinergic 
receptors which fall broadly into two families, G-protein 
coupled receptors (P2Y) and ATP-receptor activated 
membrane ion channels (P2X). ATP signal transduction 
involves intracellular Ca2+-signaling (transient increases 
in intracellular Ca2+ concentration) which occur rapidly 
Figure 6: Purinergic receptor mediated bystander effects evoke Ca2+-transients in T24 cells. (A) T24 cells, loaded with the 
Ca2+-indicator, fluo-4AM were treated with ATP (10-5M) as indicated by the horizontal bars. Responses from 2 cells within the recording 
dish are presented and show transient increases in intracellular Ca2+. After washout and incubation with the pan-purinergic receptor 
blocker, suramin (10-4M), ATP treatment was repeated and responses were markedly reduced or blocked. (B) Summary data for 51 cells 
(N=3) is presented in the bar chart where suramin significantly reduced the amplitude of ATP-evoked responses (p<0.001). (C) In another 
experimental series, T24 cells were treated with conditioned medium (CM) from non-irradiated (0 Gy) followed by a 10 minute wash 
and then CM from irradiated cells (8Gy). Four cells are shown from the recording dish. The cells responded to CM (0 Gy and 8 Gy) with 
Ca2+-transients. CM was then washed out and cells treated with suramin (10-4M) for 30 minutes before application of CM in the presence 
of suramin which blocked the responses. (D) The summary bar chart shows the percentage of cells responding to CM in the absence of 
suramin and the marked reduction of responding cells after suramin treatment (N=3, n=72).
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i.e. within seconds-minutes of exposure, subsequently 
activating downstream pathways. We found that T24 
cells release ATP and also respond to exogenous ATP 
with Ca2+-transients that were inhibited by purinergic 
receptor blockade. It was beyond the scope of the 
present study to carry out a full characterization of the 
purinergic receptors mediating ATP effects, moreover, 
the expression of purinergic receptors on T24 cells has 
not yet been reported. HT1376 cells express (P2X4,5,7 
and P2Y1,2,4,6,11)) [29], however as they did not exhibit 
bystander responses in the present study, they were 
not studied further. The bystander CM Ca2+-response 
in T24 cells was blocked by suramin demonstrating 
its mediation by purinergic receptors. Interestingly, 
CM from non-irradiated cells also evoked suramin-
sensitive Ca2+-responses, consistent with the finding 
that T24 have basal ATP release and their survival relies 
on ATP homeostasis. Our findings demonstrate that in 
Figure 7: Summary schematic. Summary schematic diagram of the radiation-bystander effect that is common to urothelial cancer (T24) 
cells and normal urothelium (SV-HUC). Directly irradiated cells signal to bystander cells activating pro-apoptotic signaling mechanisms 
and causing DNA double stand break damage resulting in decreased cell survival. The bystander effect studied here was mediated by ATP 
release from irradiated cells that acted on bystander cells.
Table 1: List of antibodies
Antibody Company Product number Host species Dilution
53BP1 (IF) Novus Biologicals NB100304 Rabbit 1:1,000
anti-rabbit Alexa Fluor 488 (IF) ThermoFisher A-11034 Goat 1:500
total caspase-3 (WB) Cell signalling 9665S Rabbit 1:1000
cleaved caspase-3 (WB) Cell signalling 9664S Rabbit 1:1000
PARP (WB) Cell signalling 9532S Rabbit 1:1000
cleaved-PARP (WB) Cell signaling 9541S Rabbit 1:500
β-actin (WB) Sigma-Aldrich A5441 Mouse 1:20,000
anti-rabbit IgG HRP (WB) Cell signalling 7074S Rabbit 1:6000
anti-mouse IgG HRP (WB) Cell signalling 7076S Mouse 1:6000
IF: immunofluorescence, WB: Western blot.
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T24 urothelial cancer cells, radiation evokes release of 
ATP which underpins bystander responses of decreased 
cell survival. Activation of the pro-apoptotic signaling 
pathway including executioner cleaved caspase 3 and 
cleaved PARP is consistent with the CM-evoked Ca2+-
responses as both caspase 3 and PARP are known to be 
Ca2+-dependent [32–34].
In conclusion, radiation activates bystander 
signaling in urothelial cancer cells which causes DNA 
damage, activation of pro-apoptotic pathways and 
reduced cell survival via ATP-purinergic, Ca2+-dependent 
mechanisms (Figure 7). This advantageous effect is 
accompanied by similar effects on normal urothelial 
cells, underpinning radiation-induced bladder toxicity 
and symptoms of radiation cystitis.
MATERIALS AND METHODS
Cell models
Urothelial carcinoma cells T24 (McCoy’s 5A) [35], 
HT1376 MEM) [36], immortalised normal urothelial 
cells SV-HUC (F12K) [37], were purchased from ATCC; 
primary normal HUC (Urothelial Cell Medium) were 
obtained from ScienCell Research Laboratories. Cells 
were cultured in their respective medium (parentheses), 
supplemented with 10% FBS and 1% penicillin-
streptomycin.
Cell irradiation
Radiation was delivered (13.3mA, 225kVp, 2mm 
Cu filtered, 0.59Gy/min; 0.5-8Gy) in an XRAD225 
X-ray cabinet (Precision X-ray Inc. Bradford, USA). 
For partial irradiations in bystander studies, 50% of T25 
flask areas was shielded with a 13.6x10.4x2.1cm3 block 
of MCP96 (MCP Ltd, Wellingborough, Northants, UK). 
Scattered dose under the shielding was 2-3% of the full 
dose delivered to the exposed region, determined using 
GAFCHROMIC® RTQA film (International Specialty 
products, Wayne, USA) [19, 27].
Clonogenic cell survival assay
Clonogenic assays were performed in non-
irradiated, uniformly-irradiated or 50% shielded T25 
flasks (shielded vs exposed) as previously described 
[19, 27]. 6-well plates were used in experiments where 
communication was inhibited with a physical barrier. 
Medium transfer experiments were performed using 
conditioned medium (CM, 0.2μm filter) from irradiated 
donor cells and transferred to non-irradiated recipient 
cells. In controls, conditioned medium refers to medium 
from non-irradiated cells transferred to naïve cells. After 
irradiation/CM transfer, flasks/plates were cultured until 
colonies (>50 cells) formed (8d T24, 12d SV-HUC, 16d 
HT1376).
Analysis of clonogenic survival assays in 
irradiation protocols
Colonies were visually counted; in T25 flasks, a 5mm 
region at the shield and flask edges was omitted; middle 
wells of 6-well plates were not analysed. Plating efficiency 
(PE) was calculated as number of colonies/number of 
cells and the surviving fraction (SF) as Experimental PE/
Control PE. Data was fitted with the linear-quadratic (LQ) 
model which defines two components of cell killing: αD, 
proportional to the dose and βD2, proportional to dose2. 
The α/β component for uniform irradiation was calculated 
using the equation SF=exp(-αD-βD2). Cell survival data 
in Figure 3 was fitted using a two-component radiation 
response model [27] which refers both to the scattered dose 
in the shielded region and a bystander component triggered 
by the dose delivered to the exposed region. As bystander 
responses typically saturate and do not affect the whole cell 
population, the non-responding cell population is defined 
as P (bystander limit), and the rate of bystander response is 
characterised by γ. The shielded region survival is therefore 
SF=P+(1-P)*exp(-γ*D), where D is the dose delivered to 
the exposed part. The initial slope of this curve is (1-P)*γ, 
comparable to α in the LQ.
DNA damage foci
Cells were seeded in slide-flasks (Nunc, UK) or 
Millicell EZ slides (Millipore, UK) where communication 
between shielded and exposed parts was inhibited. 
Cells were irradiated (1Gy) in uniformly-irradiated and 
shielded protocols, fixed one hour following irradiation 
and processed for immunofluorescence with anti-53BPI 
(Table 1) and DAPI [19, 27]. Gafchromic film placed under 
each slide flask was used to define the shielded area to be 
scored, with typically a 5mm exclusion region based on the 
Gafchromic film signal. Slides were imaged with confocal 
microscopy (Nikon C1). Laser/gain settings were identical 
for control and experimental slides. Images were captured 
as z-stacks. Negative controls were prepared with omission 
of primary antibody. Foci were scored within 5mm intervals 
on each side of the shielding [19] in 50 nuclei/sample using 
automation in Volocity software (Perkin Elmer).
ATP release
Baseline and radiation-induced ATP release in 
CM was measured using a bioluminescence assay kit 
(Sigma-Aldrich, FLAA) and a luminometer (Tecan, 
Magellan software) as per manufacturer’s instructions. 
T24 cells (2 x 106) in T25 flasks were treated with 50μM 
ARL67156 (Tocris), an ecto-ATPase inhibitor to prevent 
ATP hydrolysis, before irradiation at 0, 0.5, 2 and 8 Gy as 
described above (X-Rad 225). CM was harvested at 20 
min and 60 min post-radiation for each radiation dose and 
was mixed with the ATP bioluminescent reagent in a 5:1 
ratio. Standard curves for ATP concentration were also 
Oncotarget97341www.impactjournals.com/oncotarget
generated. Samples were aliquoted in white base 96-well 
plates before measuring the bioluminescence at 565nm. 
Raw values were processed to measure the ATP levels 
(nM) by background subtraction, normalization to cell 
count and the ATP standard curve.
Western blot
Cells were cultured to sub-confluence and irradiated 
(2Gy). Some experiments used CM, apyrase (Sigma-
Aldrich, 10U/mL, 30min) or ATP (Sigma-Aldrich, 10-
100nM, 1h). Protein expression (Table 1) was detected in 
cell lysates by Western blotting [38].
Live-cell imaging and Ca2+-fluorescence
Cells were seeded in P30 dishes (Nunc) in 
phenol red-free media and allowed to adhere overnight. 
Subsequently, cells were loaded with 1μM fluo-4AM 
(Invitrogen) for 30min in the incubator. The dish 
with loaded cells was placed under Nikon 80i upright 
epifluorescent microscope and washed for 15min by 
constant perfusion with media at room temperature (1-
2ml/min) to allow dye de-esterification. Fluo-4AM was 
excited by a mercury lamp (Nikon) and sample bleaching 
reduced by neutral density filters. Appropriate filter sets 
were used: 465-495nm excitation, dichroic mirror 505nm 
and 515-555nm emission. Recordings were made using 
a x20 (0.75NA) lens and imaged with a Nikon DQC-FS 
electron multiplying charged coupled device (EMCCD) 
camera at 20 frames per second using WinFluor software 
(v3.3.4, Dr J Dempster, University of Strathclyde) and 
saved as.IDS files.
Changes in intracellular Ca2+ concentration, were 
reflected by changes in fluorescence intensity. A circular 
region of interest (ROI) was drawn around each cell in the 
field of view and intensity F, measured. The background-
corrected ΔF was calculated by the equation ΔF=(F-F0)/F0. 
Background was measured by placing a ROI in an area of 
the dish where there were no cells. F0 is the mean baseline 
intensity of 100 frames in each recording where there was 
no activity. The amplitudes of transients were measured 
using WinFluor and summary data calculated using 
Microsoft Excel and Prism (v4.02, Graphpad). Statistical 
significance was calculated using the student’s t-test and 
data are expressed as mean ± standard error of the mean 
(SEM).
Data analysis
Data sets were generated from three independent 
experiments on different days. Technical replicates 
in multiwall plates were averaged to produce an 
experimental value; experimental values were analysed 
and expressed as mean ± SEM. Statistical significance 
was determined using Student’s t-test or one-way/two-
way ANOVA (Prism 4 or 5, Graphpad) and Dunnett’s 
multiple comparison post-hoc test with p<0.05 
considered to be significant. The ATP concentration-
response curve was fitted with non-linear regression 
(log (inhibitor) vs response, Prism) and the IC50 
calculated.
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